Novel Ocular Drug Delivery Market – Growing Interest in the Pharmaceutical Industry and the Growing Future Potential

The Novel Ocular Drug Delivery Devices Marketreport features an extensive study of the current market landscape and the likely adoption of novel ocular drug delivery devices, over the next decade.  The study features a detailed analysis of the key drivers and trends related to this evolving domain.

According to the World Health Organization (WHO), more than 2.2 billion individuals across the world suffer from some degree of vision impairment caused due to various ophthalmic disorders, such as glaucoma, trachoma, cataract, diabetic retinopathy and wet age-related macular degeneration. Around 50% of the cases are left either unaddressed and / or could have been prevented.  It is also worth highlighting that around 1.7 billion individuals worldwide are expected to lose their vision by 2050. Studies suggest that, if administered with the help of topical eye drops, around 95% of the drug is lost due to a number of challenges, such as dilution of product by tears and permeation issues related to cornea. Therefore, drug delivery formulations, such as eye drops and ointments, cannot be considered as an optimal treatment option for vision-threatening diseases.   

To request a sample report:

Owing to the concerns, there is an evident rise in the demand for effective, non-invasive drug delivery systems that are capable of overcoming bioavailability hurdles and enable delivery of the drug at the target cells, at effective concentrations, for a suitable period of time. Over time, several pharmaceutical companies across the world have undertaken various initiatives to develop novel drug delivery devices, such as sustained release implants, ocular inserts and punctal plugs, that are capable of enabling effective administration of drugs, while overcoming the existing challenges.

To order customize report:

Based on the type of ocular disorders, therapeutics can be delivered into the ocular regions. The selection of appropriate route of administration for a particular drug, depends on the target ocular tissue.

For more information, please click on the following link:

You may also be interested in the following reports:

  1. Container Closure Integrity Testing Services Market
  2. Global Autoinjectors Market
  3. Large Volume Wearable Injectors Market
  4. At-Home Blood Collection and Micro Sampling Devices Market

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

Facebook –

LinkedIn –

Twitter –

Medium –

Pinterest –

Quora –